Radiation Treatment Time and Overall Survival in Locally Advanced Non-small Cell Lung Cancer
- PMID: 28721898
- DOI: 10.1016/j.ijrobp.2017.04.004
Radiation Treatment Time and Overall Survival in Locally Advanced Non-small Cell Lung Cancer
Abstract
Purpose: Prolonged radiation treatment (RT) time (RTT) has been associated with worse survival in several malignancies. The present study investigated whether delays during RT are associated with overall survival (OS) in non-small cell lung cancer (NSCLC).
Methods and materials: The National Cancer Database was queried for patients with stage III NSCLC who had received definitive concurrent chemotherapy and fractionated RT to standard doses (59.4-70.0 Gy) and fractionation from 2004 to 2013. The RTT was classified as standard or prolonged for each treatment regimen according to the radiation dose and number of fractions. Cox proportional hazards models were used to evaluate the association between the following factors and OS: RTT, RT fractionation, demographic and pathologic factors, and chemotherapeutic agents.
Results: Of 14,154 patients, the RTT was prolonged in 6262 (44.2%). Factors associated with prolonged RTT included female sex (odds ratio [OR] 1.21, P<.0001), black race (OR 1.20, P=.001), nonprivate health insurance (OR 1.30, P<.0001), and lower income (<$63,000 annually, OR 1.20, P<.0001). The median OS was significantly worse for patients with prolonged RTT than that for those with standard RTT (18.6 vs 22.7 months, P<.0001). Furthermore, the OS worsened with each cumulative interval of delay (standard RTT vs prolonged 1-2 days, 20.5 months, P=.009; prolonged 3-5 days, 17.9 months, P<.0001; prolonged 6-9 days, 17.7 months, P<.0001; prolonged >9 days, 17.1 months, P<.0001). On multivariable analysis, prolonged RTT was independently associated with inferior OS (hazard ratio 1.21, P<.0001). Prolonged RTT as a continuous variable was also significantly associated with worse OS (hazard ratio 1.001, P=.0007).
Conclusions: Delays during RT appear to negatively affect survival for patients with locally advanced NSCLC. We have detailed the demographic and socioeconomic barriers influencing prolonged RTT as a method to address the health disparities in this regard. Cumulative interruptions of RT should be minimized.
Copyright © 2017 Elsevier Inc. All rights reserved.
Similar articles
-
Adjuvant Radiation Therapy Treatment Time Impacts Overall Survival in Gastric Cancer.Int J Radiat Oncol Biol Phys. 2015 Oct 1;93(2):326-36. doi: 10.1016/j.ijrobp.2015.05.025. Epub 2015 May 21. Int J Radiat Oncol Biol Phys. 2015. PMID: 26232857
-
Stereotactic Body Radiation Therapy and the Influence of Chemotherapy on Overall Survival for Large (≥5 Centimeter) Non-Small Cell Lung Cancer.Int J Radiat Oncol Biol Phys. 2017 Jan 1;97(1):146-154. doi: 10.1016/j.ijrobp.2016.09.036. Epub 2016 Sep 29. Int J Radiat Oncol Biol Phys. 2017. PMID: 27843029
-
Evaluating Intensity-Modulated Radiation Therapy in Locally Advanced Non-Small-Cell Lung Cancer: Results From the National Cancer Data Base.Clin Lung Cancer. 2016 Sep;17(5):398-405. doi: 10.1016/j.cllc.2016.01.007. Epub 2016 Feb 2. Clin Lung Cancer. 2016. PMID: 26936682
-
Hypofractionated vs. conventional radiation therapy for stage III non-small cell lung cancer treated without chemotherapy.Acta Oncol. 2020 Feb;59(2):164-170. doi: 10.1080/0284186X.2019.1675907. Epub 2019 Oct 12. Acta Oncol. 2020. PMID: 31608751 Free PMC article.
-
A palliative accelerated irradiation regimen (PAIR) for advanced non-small-cell lung cancer (NSCLC).Radiother Oncol. 1996 Mar;38(3):195-203. doi: 10.1016/0167-8140(96)01706-9. Radiother Oncol. 1996. PMID: 8693099 Review.
Cited by
-
Effects of Wildfire Events on California Radiation Oncology Clinics and Patients.Adv Radiat Oncol. 2023 Oct 22;9(3):101395. doi: 10.1016/j.adro.2023.101395. eCollection 2024 Mar. Adv Radiat Oncol. 2023. PMID: 38304108 Free PMC article.
-
Feasibility of fast, four-dimensional computed tomography-based O-ring LINAC plans for lung stereotactic body radiotherapy in patients with poor performance status.Front Oncol. 2023 Nov 20;13:1270677. doi: 10.3389/fonc.2023.1270677. eCollection 2023. Front Oncol. 2023. PMID: 38074663 Free PMC article.
-
Maintaining quality of life and care for cancer survivors experiencing disaster disruptions: a review of the literature.BMC Cancer. 2023 Jul 26;23(1):701. doi: 10.1186/s12885-023-11191-9. BMC Cancer. 2023. PMID: 37495955 Free PMC article. Review.
-
Effect of treatment interruptions on overall survival in patients with triple-negative breast cancer.J Natl Cancer Inst. 2023 Sep 7;115(9):1029-1035. doi: 10.1093/jnci/djad127. J Natl Cancer Inst. 2023. PMID: 37399094
-
Dosimetric benefits of adaptive radiation therapy for patients with stage III non-small cell lung cancer.Radiat Oncol. 2023 Feb 22;18(1):34. doi: 10.1186/s13014-023-02222-7. Radiat Oncol. 2023. PMID: 36814271 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
